IRWD · NASDAQ · Drug Manufacturers - Specialty & Generic

Ironwood Pharmaceuticals (IRWD)

Develops gastrointestinal therapies around LINZESS and apraglutide.

$4.53
After-hours close0.00 (0.00%)
At close$4.53(+2.72%)